全 民 健 康 保 險 年 報
National Health Insurance In Taiwan
2013-2014
ANNUAL REPORT
Disease
2005
2006
2007
2008
2009
2010
2011
2012
Asthma
32.50% 34.78% 35.17% 31.29% 31.61% 47.02% 45.45% 39.30%
Diabetes
23.52% 23.16% 24.67% 26.34% 27.56% 29.26% 31.36% 33.94%
Tuberculosis
68.78% 78.99% 91.81%
standard
fee
schedule
standard
fee
schedule
standard
fee
schedule
standard
fee
schedule
standard
fee
schedule
Breast Cancer
12.09% 12.98% 13.60% 14.64% 14.50% 14.62% 13.67% 13.43%
Hypertension
N/A
9.31%
(
Trial
basis)
6.54%
(
note)
3.93%
(
note)
2.65% 2.55% 2.94% 1.36%
Schizophrenia
N/A
40.65% 46.94% 51.20%
Hepatitis B
and C carriers
N/A
9.83% 19.37% 26.14%
Early chronic
kidney disease
N/A
20.15% 26.40%
Table 13 Percentage of Patients Treated Under Outcome-based Payment Plan
Note: Hypertension was added to the pay-for-performance plan in 2006 on a trial basis at clinics. It was introduced at
hospitals in 2007. The figure for that year and after covers the percentage of patients at both hospitals and clinics,
which partially explains the declining rate. Also, because hypertension sufferers also often have other conditions, such
as diabetes and chronic kidney disease, hypertension stopped being tracked on its own, and the pay-for-performance
plan for hypertension alone was ended in 2013.